Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
1999 1
2000 1
2001 3
2002 2
2003 5
2004 5
2005 2
2006 4
2007 1
2009 1
2010 6
2011 1
2012 4
2013 3
2014 4
2015 3
2016 4
2017 2
2018 5
2019 7
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

65 results
Results by year
Filters applied: . Clear all
Page 1
Kinase Inhibitors and Ovarian Cancer.
Katopodis P, Chudasama D, Wander G, Sales L, Kumar J, Pandhal M, Anikin V, Chatterjee J, Hall M, Karteris E. Katopodis P, et al. Among authors: karteris e. Cancers (Basel). 2019 Sep 12;11(9):1357. doi: 10.3390/cancers11091357. Cancers (Basel). 2019. PMID: 31547471 Free PMC article. Review.
Identification of cancer biomarkers of prognostic value using specific gene regulatory networks (GRN): a novel role of RAD51AP1 for ovarian and lung cancers.
Chudasama D, Bo V, Hall M, Anikin V, Jeyaneethi J, Gregory J, Pados G, Tucker A, Harvey A, Pink R, Karteris E. Chudasama D, et al. Among authors: karteris e. Carcinogenesis. 2018 Mar 8;39(3):407-417. doi: 10.1093/carcin/bgx122. Carcinogenesis. 2018. PMID: 29126163 Free PMC article.
Functional cardiac orexin receptors: role of orexin-B/orexin 2 receptor in myocardial protection.
Patel VH, Karteris E, Chen J, Kyrou I, Mattu HS, Dimitriadis GK, Rodrigo G, Antoniades C, Antonopoulos A, Tan BK, Hillhouse EW, Ng A, Randeva HS. Patel VH, et al. Among authors: karteris e. Clin Sci (Lond). 2018 Dec 13;132(24):2547-2564. doi: 10.1042/CS20180150. Print 2018 Dec 21. Clin Sci (Lond). 2018. PMID: 30467191 Free PMC article.
Surfactant Protein D as a Potential Biomarker and Therapeutic Target in Ovarian Cancer.
Kumar J, Murugaiah V, Sotiriadis G, Kaur A, Jeyaneethi J, Sturniolo I, Alhamlan FS, Chatterjee J, Hall M, Kishore U, Karteris E. Kumar J, et al. Among authors: karteris e. Front Oncol. 2019 Jul 9;9:542. doi: 10.3389/fonc.2019.00542. eCollection 2019. Front Oncol. 2019. PMID: 31338320 Free PMC article.
Engineered human mesenchymal stem cells for neuroblastoma therapeutics.
Nieddu V, Piredda R, Bexell D, Barton J, Anderson J, Sebire N, Kolluri K, Janes SM, Karteris E, Sala A. Nieddu V, et al. Among authors: karteris e. Oncol Rep. 2019 Jul;42(1):35-42. doi: 10.3892/or.2019.7152. Epub 2019 May 8. Oncol Rep. 2019. PMID: 31115546 Free PMC article.
Liquid Biopsies in Lung Cancer: Four Emerging Technologies and Potential Clinical Applications.
Chudasama D, Katopodis P, Stone N, Haskell J, Sheridan H, Gardner B, Urnovitz H, Schuetz E, Beck J, Hall M, Barr J, Sisu C, Rice A, Polychronis A, Anikin V, Karteris E. Chudasama D, et al. Among authors: karteris e. Cancers (Basel). 2019 Mar 7;11(3):331. doi: 10.3390/cancers11030331. Cancers (Basel). 2019. PMID: 30866571 Free PMC article.
Detection of Abundant Non-Haematopoietic Circulating Cancer-Related Cells in Patients with Advanced Epithelial Ovarian Cancer.
Kumar J, Chudasama D, Roberts C, Kubista M, Sjöback R, Chatterjee J, Anikin V, Karteris E, Hall M. Kumar J, et al. Among authors: karteris e. Cells. 2019 Jul 17;8(7):732. doi: 10.3390/cells8070732. Cells. 2019. PMID: 31319587 Free PMC article.
Multi-level suppression of receptor-PI3K-mTORC1 by fatty acid synthase inhibitors is crucial for their efficacy against ovarian cancer cells.
Wagner R, Stübiger G, Veigel D, Wuczkowski M, Lanzerstorfer P, Weghuber J, Karteris E, Nowikovsky K, Wilfinger-Lutz N, Singer CF, Colomer R, Benhamú B, López-Rodríguez ML, Valent P, Grunt TW. Wagner R, et al. Among authors: karteris e. Oncotarget. 2017 Feb 14;8(7):11600-11613. doi: 10.18632/oncotarget.14591. Oncotarget. 2017. PMID: 28086243 Free PMC article.
Differential expression of mTOR components in endometriosis and ovarian cancer: Effects of rapalogues and dual kinase inhibitors on mTORC1 and mTORC2 stoichiometry.
Rogers-Broadway KR, Kumar J, Sisu C, Wander G, Mazey E, Jeyaneethi J, Pados G, Tsolakidis D, Klonos E, Grunt T, Hall M, Chatterjee J, Karteris E. Rogers-Broadway KR, et al. Among authors: karteris e. Int J Mol Med. 2019 Jan;43(1):47-56. doi: 10.3892/ijmm.2018.3967. Epub 2018 Oct 31. Int J Mol Med. 2019. PMID: 30387804 Free PMC article.
Pathophysiology of Drug-Induced Hypomagnesaemia.
Katopodis P, Karteris E, Katopodis KP. Katopodis P, et al. Among authors: karteris e. Drug Saf. 2020 May 12. doi: 10.1007/s40264-020-00947-y. Online ahead of print. Drug Saf. 2020. PMID: 32399868 Review.
65 results
Jump to page
Feedback